CannBioRx Life Correlations
| ATNFW Stock | USD 0.02 0 15.49% |
The current 90-days correlation between CannBioRx Life Sciences and Artelo Biosciences is 0.02 (i.e., Significant diversification). The correlation of CannBioRx Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
CannBioRx Life Correlation With Market
Significant diversification
The correlation between CannBioRx Life Sciences and NYA is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CannBioRx Life Sciences and NYA in the same portfolio, assuming nothing else is changed.
CannBioRx |
Moving against CannBioRx Stock
| 0.47 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.42 | AXP | American Express Sell-off Trend | PairCorr |
| 0.4 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.4 | JPM | JPMorgan Chase Earnings Call Next Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CannBioRx Stock performing well and CannBioRx Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CannBioRx Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ARTLW | 18.47 | 0.89 | 0.03 | (0.10) | 21.93 | 45.06 | 108.48 | |||
| ATNF | 5.98 | (0.93) | 0.00 | 0.81 | 0.00 | 9.69 | 44.00 | |||
| RVPHW | 9.58 | 0.20 | 0.01 | 1.09 | 11.83 | 30.43 | 75.95 | |||
| ADILW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ENTXW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CannBioRx Life Corporate Executives
Elected by the shareholders, the CannBioRx Life's board of directors comprises two types of representatives: CannBioRx Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CannBioRx. The board's role is to monitor CannBioRx Life's management team and ensure that shareholders' interests are well served. CannBioRx Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CannBioRx Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pr Nanchahal | CoFounder Board | Profile | |
| Ozan CFA | CFO Secretary | Profile |